Celleqore

Celleqore is a boutique Contract Research Organization (CRO) specializing in next-generation flow cytometry, multiomics biomarker analysis, preclinical and clinical development, and ex vivo assays. Our mission is to enhance clinical drug efficacy by providing comprehensive, data-driven biomarker insights. We encourage biotech, pharmaceutical, and life sciences companies to rethink conventional drug discovery methods which often result in disappointing Phase 2 outcomes. By leveraging next-generation technologies and advanced analytical strategies, we aim to deliver the transformative solutions needed to bring better therapies and drug options to patients facing complex diseases. Core Competencies 1)Advanced Flow Cytometry & Immune Profiling – Multiparametric immune monitoring for oncology, autoimmune, and inflammatory diseases. 2) Multiomics Biomarker Analysis – Integrated genomic, transcriptomic, and proteomic assays to drive biomarker discovery. 3) Preclinical & Clinical Development Support – In vitro and ex vivo models to evaluate drug efficacy, safety, and mechanism of action. 4) Custom Assay Development – Tailored solutions for biomarker validation, PK/PD studies, and cellular response assessments. Differentiators -Boutique, Client-Focused Approach – Personalized service with a flexible, collaborative partnership model. -Strategic Location – Based in the NJ Bioscience Center, we are well-positioned to support Tri-State area research hubs. -Expert-Led Innovation – Team of highly experienced scientists, immunologists, & oncologists. -Industry Partnerships – Collaborations with CLIA/CAP-certified CROs, leading research incubators, & regulatory specialists. Key Clients & Partnerships -Pharmaceutical and biotechnology companies -Cell and gene therapy developers -Immuno-oncology and autoimmune drug developers -CROs -Academic and research institutions Let's Collaborate! Contact us today to explore how we can support your research and clinical programs.